20/20 Pharma, published by IMI, is a magazine which presents insightful analysis of current events, developments, and trends in the pharmaceutical world.
Innovation cannot spur change without the appropriate venues for collaboration and discussion - this space is where 20/20 Pharma resides.
With an array of new techniques surfacing in R&D, and as companies work to overcome the challenges of efficient drug development in a highly regulatory environment, the U.S. pharma industry is moving forward with the aid of top vendors and open lines of communication.
20/20 Pharma facilitates those conversations, by providing a platform of communication where industry leaders can exchange opinions, ideas, insights and experiences - from savvy business and marketing strategies to tactics for better clinical trials and more efficient drug discovery.
The publication has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision makers to have the means to procure and plan implementation strategies based on the topics covered.
Positioned to be an authoritative resource within top pharma companies as well as small, specialty and biotech businesses, 20/20 Pharma is geared to a highly targeted and responsive audience, bridging the gap between the industries top issues and the solutions top-tier vendors can provide.
http://2020pharma.com
